Ligand validation:7QU5

YVR: gamma-Valerolactone

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7QU5_YVR_A_503	92%	72%	0.079	0.976	0.47	0.47	-	-	1	0	100%	1
7QU5_YVR_A_504	70%	75%	0.105	0.924	0.48	0.4	-	-	0	0	100%	0.5
5MG9_YVR_A_107	31%	16%	0.153	0.822	2.25	1.35	1	1	0	0	100%	1
8DK0_YVR_A_403	4%	87%	0.224	0.624	0.42	0.22	-	-	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.